Study on Safety and Feasibility of Termination of Early Pregnancy with Cicatrix Uterus by Combined Use of Mifepristone and Misoprostol
- VernacularTitle:RU486配伍米索前列醇中止瘢痕子宫早孕的安全性及可行性探讨
- Author:
Jianping XU
;
Hanping CHEN
;
Zongzhou XU
- Publication Type:Journal Article
- Keywords:
Mifepristone;
Misoprostol;
Uterus,cicatrix;
First trimester pregnancy
- From:
Acta Medicinae Universitatis Scientiae et Technologiae Huazhong
2000;29(5):445-447
- CountryChina
- Language:Chinese
-
Abstract:
To study the safety and feasibility of Mifepristone combined with Misoprostol terminating early pregnancy after cesarean section, mifepristone combined with misoprostol was used to terminate early pregnancy in 188 women requesting medical abortion. Among them, 27 cases were uterine cicatrix. The results showed that the complete abortion rate in 188 cases was 91.48 % after administration, that in 27 cases of unterine cicatrix was 100 % and that in 161 cases of no uterine cicatrix was 90. 06 % (P＞0. 05). There were no differences in the duration of vaginal bleeding and time from the Misoprostol intake to the expulsion of gestational sac and chorionic villi between the two groups (P＞0. 05). It was suggested that combined administration of Mifepristone and Misoprostol to terminate early pregancy is safe and effective after cesarean section.
